抗GPIbα抗体诱导小鼠免疫性血小板减少症的机制研究
该研究利用大鼠抗小鼠GPIbα单克隆抗体5A7建立两种小鼠免疫性血小板减少症模型:单次静脉注射高剂量(2 mg/kg)5A7后,调理血小板迅速被脾和肝清除,伴TPO mRNA快速上调;而每3天皮下注射低剂量5A7(0.08-0.16 mg/kg)则逐渐降低血小板计数,调理血小板仅见于脾,TPO水平不变。两种模型中5A7均结合并内化至骨髓巨核细胞,慢性期生成的血小板表面GPIbα表达降低。
要点
- 高剂量5A7静脉注射致血小板快速清除,脾肝参与,TPO mRNA上调。
- 低剂量5A7皮下注射致渐进性血小板减少,仅脾清除,TPO不变。
- 5A7结合并内化至骨髓巨核细胞,慢性期血小板GPIbα表达降低。
核心结论
- 抗GPIbα抗体通过不同机制诱导血小板减少,取决于抗体剂量与给药途径。
- 评估血小板表面GPIbα与血小板大小的相对关系可能有助于诊断抗GPIbα抗体诱导的ITP。
研究设计与样本
- 使用大鼠抗小鼠GPIbα单克隆抗体5A7建立两种小鼠免疫性血小板减少症模型。
- 模型一:单次静脉注射高剂量5A7(2 mg/kg)。
- 模型二:每3天皮下注射低剂量5A7(0.08-0.16 mg/kg)。
主要发现
- 高剂量静脉注射后,调理血小板迅速从循环清除至脾和肝,伴TPO mRNA快速上调。
- 低剂量皮下注射后,血小板计数逐渐降低,调理血小板仅见于脾,TPO水平不变。
- 两种模型中5A7均存在于骨髓巨核细胞表面并内化至细胞内。
- 慢性期反复皮下注射5A7模型生成的血小板表面GPIbα膜表达降低。
临床怎么用
- 监测血小板表面GPIbα相对血小板大小可能辅助诊断抗GPIbα抗体诱导的ITP。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immune thrombocytopenia (ITP) is an acquired bleeding disorder characterized by antibody-mediated platelet destruction. Different mechanisms have been suggested to explain accelerated platelet clearance and impaired thrombopoiesis, but the pathophysiology of ITP has yet to be fully delineated. In this study, we tested 2 mouse models of immune-mediated thrombocytopenia using the rat anti-mouse GPIbα monoclonal antibody 5A7, generated in our laboratory. After a single IV administration of high-dose (2 mg/kg) 5A7, opsonized platelets were rapidly cleared from the circulation into the spleen and liver; this was associated with rapid upregulation of thrombopoietin (TPO) messenger RNA. In contrast, subcutaneous administration of low-dose 5A7 (0.08-0.16 mg/kg) every 3 days gradually lowered the platelet count; in this case, opsonized platelets were observed only in the spleen, and TPO levels remained unaltered. Interestingly, in both models, the 5A7 antibody was found on the surface of, as well as internalized to, bone marrow megakaryocytes. Consequently, platelets generated in the chronic phase of repeated subcutaneous 5A7 administration model showed reduced GPIbα membrane expression on their surface. Our findings indicate that evaluation of platelet surface GPIbα relative to platelet size may be a useful marker to support the diagnosis of anti-GPIbα antibody-induced ITP.
引用
- Morodomi Y, Kanaji S, Won E, et al. Mechanisms of anti-GPIbα antibody-induced thrombocytopenia in mice. Blood. 2020. PMID: 32157300. doi:10.1182/blood.2019003770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。